Tim Buckley elected to Pfizer’s Board of Directors
Buckley served as Chairman and Chief Executive Officer at Vanguard from 2018 until his retirement in 2024
Buckley served as Chairman and Chief Executive Officer at Vanguard from 2018 until his retirement in 2024
We now rank 3rd in pharmaceutical production by volume and 14th by value
A new initiative to contribute to enhancing drug discovery capabilities in the field of gene and cell therapy in Japan
Nearly 200 participants from 50 Unani Academia and Council participated
He advocated for a "PPP + PPP" collaboration, urging the public and private sectors within India to partner with their counterparts in other countries
Campaign launched to spread awareness regarding dengue prevention and control
Partnership to facilitate collaborative research in academia and industry to further progress in life sciences
This alliance brings together drug innovation capabilities of Glenmark and Ichnos to develop cutting-edge therapies for the treatment of hematological malignancies and solid tumors
Automated parallel capillary electrophoresis system simplifies protein analysis
Subscribe To Our Newsletter & Stay Updated